Tilman D. Rachner

5.2k total citations · 1 hit paper
74 papers, 3.9k citations indexed

About

Tilman D. Rachner is a scholar working on Oncology, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, Tilman D. Rachner has authored 74 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 45 papers in Molecular Biology and 15 papers in Orthopedics and Sports Medicine. Recurrent topics in Tilman D. Rachner's work include Bone health and treatments (40 papers), Bone Metabolism and Diseases (20 papers) and Wnt/β-catenin signaling in development and cancer (10 papers). Tilman D. Rachner is often cited by papers focused on Bone health and treatments (40 papers), Bone Metabolism and Diseases (20 papers) and Wnt/β-catenin signaling in development and cancer (10 papers). Tilman D. Rachner collaborates with scholars based in Germany, United States and Austria. Tilman D. Rachner's co-authors include Lorenz C. Hofbauer, Sundeep Khosla, Martina Rauner, Andy Göbel, Robert E. Coleman, Franz Jakob, Peyman Hadji, Stefanie Thiele, Nikolai Jaschke and Michael Schoppet and has published in prestigious journals such as Cell, The Lancet and Biomaterials.

In The Last Decade

Tilman D. Rachner

70 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteoporosis: now and the future

2011 2.1k citations Tilman D. Rachner, Lorenz C. Hofbauer et al. profile →

Peers

Countries citing papers authored by Tilman D. Rachner

Since Specialization

Citations

This map shows the geographic impact of Tilman D. Rachner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman D. Rachner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman D. Rachner more than expected).

Fields of papers citing papers by Tilman D. Rachner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilman D. Rachner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman D. Rachner. The network helps show where Tilman D. Rachner may publish in the future.

Co-authorship network of co-authors of Tilman D. Rachner

This figure shows the co-authorship network connecting the top 25 collaborators of Tilman D. Rachner. A scholar is included among the top collaborators of Tilman D. Rachner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilman D. Rachner. Tilman D. Rachner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase 2024 ·Biochemical and Biophysical Research Communications ·Andy Göbel, (unknown), (unknown), (unknown), Sofia Traikov, Lorenz C. Hofbauer, Tilman D. Rachner	7
2	High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer 2024 ·Archives of Gynecology and Obstetrics ·Andy Göbel, Tilman D. Rachner, Oliver Hoffmann, Daniel Martin Klotz, Sabine Kasimir‐Bauer, Rainer Kimmig, Lorenz C. Hofbauer, Ann‐Kathrin Bittner	3
3	Cancer cachexia as a blueprint for treating obesity 2023 ·Trends in Endocrinology and Metabolism ·Nikolai Jaschke, Tilman D. Rachner	3
4	Dickkopf1 fuels inflammatory cytokine responses 2022 ·Communications Biology ·Nikolai Jaschke, (unknown), Anupam Sinha, Timon E. Adolph, María G. Ledesma-Colunga, (unknown), Andrew Wang, Sylvia Thiele, Julian Schwärzler, (unknown), Marc Gentzel, Herbert Tilg, Ben Wielockx, Lorenz C. Hofbauer, Martina Rauner, Andy Göbel, Tilman D. Rachner	10
5	Skeletal endocrinology: where evolutionary advantage meets disease 2021 ·Bone Research ·Nikolai Jaschke, Wolfgang Sipos, Lorenz C. Hofbauer, Tilman D. Rachner, Martina Rauner	10
6	Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer 2018 ·Clinical Cancer Research ·Tilman D. Rachner, Sabine Kasimir‐Bauer, Andy Göbel, Kati Erdmann, Oliver Hoffmann, Andrew Browne, Pauline Wimberger, Martina Rauner, Lorenz C. Hofbauer, Rainer Kimmig, Ann‐Kathrin Bittner	29
7	Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer 2017 ·Breast Cancer Research ·(unknown), (unknown), Andy Göbel, Peyman Hadji, David Chen, Martina Rauner, Friedrich Stölzel, Lorenz C. Hofbauer, Tilman D. Rachner	23
8	p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells 2016 ·Cell Death and Disease ·(unknown), Andy Göbel, Stefanie Thiele, Lorenz C. Hofbauer, Martina Rauner, Tilman D. Rachner	42
9	Cancer-targeted therapies and radiopharmaceuticals 2015 ·BoneKEy Reports ·Tilman D. Rachner, Franz Jakob, Lorenz C. Hofbauer	1
10	P38 regulates the Wnt inhibitor Dickkopf-1 in breast cancer 2015 ·Biochemical and Biophysical Research Communications ·Tilman D. Rachner, Andy Göbel, (unknown), (unknown), Martina Rauner, Lorenz C. Hofbauer	11
11	Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins 2015 ·Breast Cancer Research and Treatment ·Andy Göbel, (unknown), Stefanie Thiele, Martina Rauner, Lorenz C. Hofbauer, Tilman D. Rachner	15
12	Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells 2014 ·Molecular Cancer ·Regina Ebert, Jutta Meißner-Weigl, Sabine Zeck, Jorma A. Määttä, Seppo Auriola, Sofia Sousa, Birgit Mentrup, (unknown), Tilman D. Rachner, Lorenz C. Hofbauer, Franz Jakob	17
13	Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer 2014 ·Journal of Cancer Research and Clinical Oncology ·Ioannis Kyvernitakis, Tilman D. Rachner, Anja Urbschat, O. Hars, Lorenz C. Hofbauer, Peyman Hadji	26
14	Dickkopf-1 as a mediator and novel target in malignant bone disease 2014 ·Cancer Letters ·Tilman D. Rachner, Andy Göbel, (unknown), Lorenz C. Hofbauer, Martina Rauner	34
15	Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin 2013 ·Journal of bone oncology ·(unknown), Stefanie Thiele, Tilman D. Rachner, Andy Göbel, Martina Rauner, Lorenz C. Hofbauer	9
16	Regulation of VEGF by mevalonate pathway inhibition in breast cancer 2013 ·Journal of bone oncology ·Tilman D. Rachner, Andy Göbel, (unknown), (unknown), (unknown), Peyman Hadji, Lorenz C. Hofbauer	10
17	The anti-progestin RU-486 inhibits viability of MCF-7 breast cancer cells by suppressing WNT1 2011 ·Cancer Letters ·(unknown), Martina Rauner, Tilman D. Rachner, Lorenz C. Hofbauer	13
18	Seizures Associated with Zoledronic Acid for Osteoporosis 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Elena Tsourdi, Tilman D. Rachner, (unknown), Christine Hamann, Tjalf Ziemssen, Lorenz C. Hofbauer	15
19	Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells 2011 ·Bone ·Regina Ebert, Sabine Zeck, Jutta Meißner-Weigl, Barbara Klotz, Tilman D. Rachner, (unknown), Ludger Klein‐Hitpaß, Maximilian Rudert, Lorenz C. Hofbauer, Franz Jakob	20
20	Regenerative potential of glycosaminoglycans for skin and bone 2011 ·Journal of Molecular Medicine ·Juliane Salbach‐Hirsch, Tilman D. Rachner, Martina Rauner, Ute Hempel, Ulf Anderegg, Sandra Franz, Jan‐Christoph Simon, Lorenz C. Hofbauer	169

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact